🔗 Share this article

A shadow market for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on recent findings.

Experimental Drug Gaining Popularity Online

The experimental drug, which remains in research studies, is being advertised by online personalities for its supposed weight-reducing properties. Followers are urged to contact these accounts directly for source information, while also receiving promotional offers.

Thriving Commerce on Messaging Platforms

Additionally, a robust trade exists on Telegram, where groups with numerous of members share comparison images, administration instructions and claims of rapid UK delivery. Sellers promote the substance there before directing buyers to WhatsApp for transactions.

Understanding The Experimental Drug

Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the successor to Ozempic.

Healthcare Experts Voice Worries

Nevertheless, physicians and chemists have cautions that the distribution of what is still an unapproved drug in the UK is worrisome and could result in users injecting substances of uncertain source.

Some professionals said the popularity for the experimental drug could be connected to the rising price of approved slimming products such as Mounjaro.

Regulatory Status and Implementation

Marketing the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unapproved medication that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.

Some content creators attempt to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still breach pharmaceutical, marketing, and customer regulations, risking fines, prosecution or imprisonment.

Service Reaction and Material Removal

According to the social media company, the platform has removed violative material and prohibited associated keywords and search suggestions. The company said it was dedicated to maintaining the platform secure and investing in strengthening enforcement strategies.

Digital Marketplace Activities

Investigations also found groups with up to 9,000 participants selling retatrutide using Telegram's integrated discovery tool, which functions like a online catalog. Typing “retatrutide” immediately brings up channels with numerous of members, filled with photos of slimming results, positive testimonials and detailed guides for preparing or injecting at home.

After minutes of joining one group, a vendor posted WhatsApp details, where most transactions take place. The seller provided an instruction manual and promised delivery within 48 hours. When asked whether the substance was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one asked about body mass, medical conditions or past usage.

Item Details and Pricing

Inside these groups, messages show black plastic parcels with Royal Mail stickers, stating to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at residence with purified liquid, or ready-to-use pens typically priced at 160 pounds for 20mg. When questioned how much time a injector should be used, sellers give conflicting answers varying between a few weeks to “depends on your body”.

Platform Oversight and Safety Actions

A representative for the messaging service said it actively monitored dangerous content on its platform including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are administering substances they can’t verify. Even if the research behind retatrutide is sound, these online products may not contain what they advertise,” said Jason Murphy, the head of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor linked the surge in demand to recent price rises for approved weight-loss drugs such as Mounjaro. “With costs rising, patients are turning to online platforms. But fake treatments are highly dangerous. You cannot know what’s inside or whether the environment they were made in was sterile,” she explained.

Her staff has already seen individuals injured by self-injection from unverified sources. “We recognize the disappointment, but buying from messaging apps or WhatsApp is gambling with your well-being,” stated Wyllie. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Statement

A representative from the pharmaceutical company said the substance was in third stage research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this time no one can market [it] for human use,” they said, adding that any item “falsely representing itself as a Lilly investigational substance not yet authorized … may subject patients to potentially serious medical dangers”.